logo

Olanzapine and Autism Ranking: Mildly Hazardous Limited positive evidence

Additional Information

NICE Guidance

The National Institute for Health Care Excellence has provided clinical guidance on the use of pharmacological interventions (such as olanzapine) for behaviour that challenges in autistic children and young people.

 

Related Additional Information


Updated
17 Jun 2022
Last Review
01 Feb 2016
Next Review
01 Feb 2019